Company Announcements

Results analysis from Kepler Trust Intelligence

Source: RNS
RNS Number : 1911J
BlackRock Frontiers Investment Tst
18 December 2020
 

BlackRock Frontiers (BRFI)

18/12/2020

Results analysis from Kepler Trust Intelligence

·       BlackRock Frontiers released its final results for the year ending 30 September 2020 last week, showing a decline in its NAV of 20%, relative to a fall of 15% from the benchmark - a bespoke index which tracks the emerging and frontier markets excluding the largest eight.

·       However, since the financial year end the trust has seen a sharp rise in absolute and relative performance as news of a COVID vaccine has lifted spirits, delivering NAV returns of 27.9% compared with a rise in the benchmark of 15.5% between the financial year end and 11 December 2020.

·       Having traded on a consistent premium for most of its recent life the trust started 2020 on a premium of 7.2%, but by its financial year end in September had moved to a discount of -4.9%. Although the discount has narrowed slightly since, it could still be a potentially attractive entry point for those seeking exposure to this highly differentiated strategy, with its unique focus on 'truly emerging' markets.

 

Kepler View

The dramatic snap-back in the performance of BlackRock Frontiers since the news of a breakthrough on a vaccine for Coronavirus began to filter through underlines what could be an interesting entry point for investors seeking exposure to emerging markets, and puts the trust back on the front foot after a difficult year.

The current discount (-1.5%) - even though it has tightened in recent weeks - may well prove attractive as a potential entry point for some investors - given that for most of the last five years BRFI has traded on a premium to NAV.

Click here to continue reading…

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP.  The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.  

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABDBDDGXBDGGI